The role of natriuretic peptides in heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-05-15

AUTHORS

Daniel D. Correa de Sa, Horng H. Chen

ABSTRACT

Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides. More... »

PAGES

182

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11886-008-0032-2

DOI

http://dx.doi.org/10.1007/s11886-008-0032-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026903509

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18489861


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Insufficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renin-Angiotensin System", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Correa de Sa", 
        "givenName": "Daniel D.", 
        "id": "sg:person.01142276110.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142276110.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guggenheim 915, Mayo Clinic and Foundation, Cardiorenal Research Laboratory, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Guggenheim 915, Mayo Clinic and Foundation, Cardiorenal Research Laboratory, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/b:pham.0000048203.30568.81", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004340827", 
          "https://doi.org/10.1023/b:pham.0000048203.30568.81"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10741-005-6132-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053031993", 
          "https://doi.org/10.1007/s10741-005-6132-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-05-15", 
    "datePublishedReg": "2008-05-15", 
    "description": "Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11886-008-0032-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021175", 
        "issn": [
          "1523-3782", 
          "1534-3170"
        ], 
        "name": "Current Cardiology Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "natriuretic peptide", 
      "heart failure", 
      "decompensated congestive heart failure", 
      "exogenous natriuretic peptides", 
      "natriuretic peptide levels", 
      "congestive heart failure", 
      "renal dysfunction", 
      "aldosterone system", 
      "initial injury", 
      "prognostic value", 
      "clinical syndrome", 
      "peptide levels", 
      "US Food", 
      "Drug Administration", 
      "physiologic properties", 
      "endogenous peptides", 
      "more studies", 
      "cellular adaptation", 
      "peptides", 
      "failure", 
      "natriuresis", 
      "vasodilatation", 
      "patients", 
      "multiorgan", 
      "dysfunction", 
      "syndrome", 
      "therapy", 
      "injury", 
      "cardiac", 
      "administration", 
      "neurohormones", 
      "important role", 
      "key role", 
      "role", 
      "unique family", 
      "food", 
      "levels", 
      "study", 
      "action", 
      "family", 
      "potential", 
      "investigation", 
      "adaptation", 
      "full potential", 
      "values", 
      "system", 
      "process", 
      "properties", 
      "progressive cardiac", 
      "complex multiorgan", 
      "important physiologic properties", 
      "advanced decompensated congestive heart failure"
    ], 
    "name": "The role of natriuretic peptides in heart failure", 
    "pagination": "182", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026903509"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11886-008-0032-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18489861"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11886-008-0032-2", 
      "https://app.dimensions.ai/details/publication/pub.1026903509"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_468.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11886-008-0032-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11886-008-0032-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11886-008-0032-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11886-008-0032-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11886-008-0032-2'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      22 PREDICATES      89 URIs      79 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11886-008-0032-2 schema:about N13119415c99f4855b00f0fdabc27d5e8
2 N1f928b127fde4d0ca7a58d48835c8870
3 N276d4d2e3ff14f06a8b71d36ef11bc5a
4 N2bf0b0f48b21426fa248937a477b9beb
5 N3bd61f86de604d3f9087b62e51888697
6 N40a0b43019cf4ba2879186f5c4959084
7 N551c7e2cf40b4260ae4bb3a2a58d7ceb
8 N63fb680b93954e29915aca0026241801
9 Ndc4d3157f43445c0988f9920d6b0607c
10 anzsrc-for:11
11 anzsrc-for:1102
12 schema:author N80300854840e4401977c4532ce179e21
13 schema:citation sg:pub.10.1007/s10741-005-6132-9
14 sg:pub.10.1023/b:pham.0000048203.30568.81
15 schema:datePublished 2008-05-15
16 schema:datePublishedReg 2008-05-15
17 schema:description Heart failure is a clinical syndrome associated with progressive cardiac, vascular, and renal dysfunction. Regardless of the initial injury, investigations have demonstrated that neurohormones play an important role in the complex multiorgan and cellular adaptations. Natriuretic peptides play a key role in this process, antagonizing the actions of the renin-angiotensin-aldosterone system, thus promoting vasodilatation and natriuresis. Other important physiologic properties of the natriuretic peptides are prolusitropic, sympathoinhibitory, antiproliferative, anti-ischemic, anti-inflammatory, and antioxidative. Administering exogenous natriuretic peptide is a US Food and Drug Administration-approved therapy for patients with advanced decompensated congestive heart failure. Also, measuring natriuretic peptide levels has diagnostic and prognostic value. More studies are needed to define the full potential of this unique family of endogenous peptides.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf Na68cf15db47f4f0cba8aeed05876bb86
22 Nba9fe85c54934b2ca71d7642d9b5943a
23 sg:journal.1021175
24 schema:keywords Drug Administration
25 US Food
26 action
27 adaptation
28 administration
29 advanced decompensated congestive heart failure
30 aldosterone system
31 cardiac
32 cellular adaptation
33 clinical syndrome
34 complex multiorgan
35 congestive heart failure
36 decompensated congestive heart failure
37 dysfunction
38 endogenous peptides
39 exogenous natriuretic peptides
40 failure
41 family
42 food
43 full potential
44 heart failure
45 important physiologic properties
46 important role
47 initial injury
48 injury
49 investigation
50 key role
51 levels
52 more studies
53 multiorgan
54 natriuresis
55 natriuretic peptide
56 natriuretic peptide levels
57 neurohormones
58 patients
59 peptide levels
60 peptides
61 physiologic properties
62 potential
63 process
64 prognostic value
65 progressive cardiac
66 properties
67 renal dysfunction
68 role
69 study
70 syndrome
71 system
72 therapy
73 unique family
74 values
75 vasodilatation
76 schema:name The role of natriuretic peptides in heart failure
77 schema:pagination 182
78 schema:productId N14a75b5cad994d2cb7619bdd63e169c6
79 N3a8bfdf1a61541fb9aad14369af96455
80 Na682ff3abd19497f87fe423052755ea8
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026903509
82 https://doi.org/10.1007/s11886-008-0032-2
83 schema:sdDatePublished 2022-01-01T18:18
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Na64e5f48c7964bfdbed1ba5ef5575766
86 schema:url https://doi.org/10.1007/s11886-008-0032-2
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N13119415c99f4855b00f0fdabc27d5e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Heart Failure
92 rdf:type schema:DefinedTerm
93 N14a75b5cad994d2cb7619bdd63e169c6 schema:name doi
94 schema:value 10.1007/s11886-008-0032-2
95 rdf:type schema:PropertyValue
96 N1f928b127fde4d0ca7a58d48835c8870 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Acute Disease
98 rdf:type schema:DefinedTerm
99 N276d4d2e3ff14f06a8b71d36ef11bc5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Natriuretic Peptides
101 rdf:type schema:DefinedTerm
102 N2bf0b0f48b21426fa248937a477b9beb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Myocardial Infarction
104 rdf:type schema:DefinedTerm
105 N3a8bfdf1a61541fb9aad14369af96455 schema:name dimensions_id
106 schema:value pub.1026903509
107 rdf:type schema:PropertyValue
108 N3bd61f86de604d3f9087b62e51888697 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Renin-Angiotensin System
110 rdf:type schema:DefinedTerm
111 N40a0b43019cf4ba2879186f5c4959084 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Renal Insufficiency
113 rdf:type schema:DefinedTerm
114 N551c7e2cf40b4260ae4bb3a2a58d7ceb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Humans
116 rdf:type schema:DefinedTerm
117 N63fb680b93954e29915aca0026241801 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Hypertension
119 rdf:type schema:DefinedTerm
120 N80300854840e4401977c4532ce179e21 rdf:first sg:person.01142276110.80
121 rdf:rest Nae889adc1cd64f6380fb3632d6559dcd
122 Na64e5f48c7964bfdbed1ba5ef5575766 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 Na682ff3abd19497f87fe423052755ea8 schema:name pubmed_id
125 schema:value 18489861
126 rdf:type schema:PropertyValue
127 Na68cf15db47f4f0cba8aeed05876bb86 schema:volumeNumber 10
128 rdf:type schema:PublicationVolume
129 Nae889adc1cd64f6380fb3632d6559dcd rdf:first sg:person.01024326700.50
130 rdf:rest rdf:nil
131 Nba9fe85c54934b2ca71d7642d9b5943a schema:issueNumber 3
132 rdf:type schema:PublicationIssue
133 Ndc4d3157f43445c0988f9920d6b0607c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Biomarkers
135 rdf:type schema:DefinedTerm
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
140 schema:name Cardiorespiratory Medicine and Haematology
141 rdf:type schema:DefinedTerm
142 sg:journal.1021175 schema:issn 1523-3782
143 1534-3170
144 schema:name Current Cardiology Reports
145 schema:publisher Springer Nature
146 rdf:type schema:Periodical
147 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
148 schema:familyName Chen
149 schema:givenName Horng H.
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
151 rdf:type schema:Person
152 sg:person.01142276110.80 schema:familyName Correa de Sa
153 schema:givenName Daniel D.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142276110.80
155 rdf:type schema:Person
156 sg:pub.10.1007/s10741-005-6132-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053031993
157 https://doi.org/10.1007/s10741-005-6132-9
158 rdf:type schema:CreativeWork
159 sg:pub.10.1023/b:pham.0000048203.30568.81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004340827
160 https://doi.org/10.1023/b:pham.0000048203.30568.81
161 rdf:type schema:CreativeWork
162 grid-institutes:grid.66875.3a schema:alternateName Guggenheim 915, Mayo Clinic and Foundation, Cardiorenal Research Laboratory, 200 First Street SW, 55905, Rochester, MN, USA
163 schema:name Guggenheim 915, Mayo Clinic and Foundation, Cardiorenal Research Laboratory, 200 First Street SW, 55905, Rochester, MN, USA
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...